DK1487499T3 - Kontrastmidler til magnetisk resonansbilleddannelse og relaterede fremgangsmåder - Google Patents

Kontrastmidler til magnetisk resonansbilleddannelse og relaterede fremgangsmåder

Info

Publication number
DK1487499T3
DK1487499T3 DK03716374T DK03716374T DK1487499T3 DK 1487499 T3 DK1487499 T3 DK 1487499T3 DK 03716374 T DK03716374 T DK 03716374T DK 03716374 T DK03716374 T DK 03716374T DK 1487499 T3 DK1487499 T3 DK 1487499T3
Authority
DK
Denmark
Prior art keywords
contrast agents
magnetic resonance
resonance imaging
related methods
provides methods
Prior art date
Application number
DK03716374T
Other languages
English (en)
Inventor
Eric T Ahrens
Original Assignee
Univ Carnegie Mellon
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Carnegie Mellon filed Critical Univ Carnegie Mellon
Application granted granted Critical
Publication of DK1487499T3 publication Critical patent/DK1487499T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/14—Peptides, e.g. proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1896—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes not provided for elsewhere, e.g. cells, viruses, ghosts, red blood cells, virus capsides
DK03716374T 2002-03-07 2003-03-07 Kontrastmidler til magnetisk resonansbilleddannelse og relaterede fremgangsmåder DK1487499T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36316302P 2002-03-07 2002-03-07
PCT/US2003/007018 WO2003075747A2 (en) 2002-03-07 2003-03-07 Contrast agents for magnetic resonance imaging and methods related thereto

Publications (1)

Publication Number Publication Date
DK1487499T3 true DK1487499T3 (da) 2009-07-20

Family

ID=27805266

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03716374T DK1487499T3 (da) 2002-03-07 2003-03-07 Kontrastmidler til magnetisk resonansbilleddannelse og relaterede fremgangsmåder

Country Status (11)

Country Link
US (1) US8084017B2 (da)
EP (1) EP1487499B1 (da)
JP (2) JP2005518816A (da)
AT (1) ATE433331T1 (da)
AU (2) AU2003220084B2 (da)
CA (1) CA2478120C (da)
DE (1) DE60327927D1 (da)
DK (1) DK1487499T3 (da)
ES (1) ES2327912T3 (da)
IL (2) IL163937A0 (da)
WO (1) WO2003075747A2 (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003207508A (ja) * 2002-01-09 2003-07-25 Japan Science & Technology Corp 遺伝子発現のモニタリング方法
US7998704B2 (en) * 2002-03-07 2011-08-16 Carnegie Mellon University Methods for magnetic resonance imaging
CA2478120C (en) * 2002-03-07 2016-01-12 Carnegie Mellon University Contrast agents containing ferritin for magnetic resonance imaging and methods related thereto
EA011594B1 (ru) * 2004-12-30 2009-04-28 Синвеншен Аг Композиция, включающая агент, обеспечивающий сигнал, имплантируемый материал и лекарство
US7713232B2 (en) * 2005-11-04 2010-05-11 Medrad, Inc. System for washing and processing of cells for delivery thereof to tissue
US8182444B2 (en) * 2005-11-04 2012-05-22 Medrad, Inc. Delivery of agents such as cells to tissue
WO2007092740A2 (en) * 2006-02-07 2007-08-16 The Regents Of The University Of California Method and system for the amplification of nuclear magnetic resonance imaging
TW200819540A (en) 2006-07-11 2008-05-01 Genelux Corp Methods and compositions for detection of microorganisms and cells and treatment of diseases and disorders
DE102007015598A1 (de) 2007-03-29 2008-10-02 Heinrich-Heine-Universität Düsseldorf Verwendung von fluorhaltigen Verbindungen zu Diagnosezwecken mit Hilfe bildgebender Verfahren
WO2009032160A2 (en) * 2007-08-28 2009-03-12 Massachusetts Institute Of Technology Metalloprotein mri contrast agents and related methods
JP5325427B2 (ja) * 2008-02-20 2013-10-23 株式会社Ｉｈｉ 磁性を有する薬剤
KR101029765B1 (ko) * 2008-06-12 2011-04-19 서울대학교병원 페리틴 유전자를 포함하는 렌티바이러스 벡터 및 그의 용도
GB0812191D0 (en) * 2008-07-03 2008-08-13 Greater Glasgow Health Board Modified cells and methods of monitoring their viability
NZ724348A (en) 2010-11-30 2019-12-20 Genentech Inc Low affinity blood brain barrier receptor antibodies and uses therefor
US9387264B2 (en) 2012-04-05 2016-07-12 Yeda Research And Development Co. Ltd. Reporter genes for magnetic resonance imaging and methods of use thereof
CA2921493A1 (en) * 2012-08-21 2014-02-27 Brown University Ferritin-based tumor targeting agent, and imaging and treatment methods
EP2783703A1 (en) 2013-03-25 2014-10-01 B. Braun Melsungen AG Semifluorocarbon compound containing contrast agent
CN106324008B (zh) * 2015-07-02 2018-10-16 中国石油天然气股份有限公司 核磁共振测井波谱的校正方法
CN106680509A (zh) * 2016-12-27 2017-05-17 山东爱维德生物科技有限公司 铁蛋白定量检测试剂盒、其制备及使用方法
GB202004892D0 (en) * 2020-04-02 2020-05-20 Governing Council Of The Univ Of Toronto Ferritin for cellular tracking utilizing T1-weighted MRI

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5922304A (en) * 1989-12-22 1999-07-13 Imarx Pharmaceutical Corp. Gaseous precursor filled microspheres as magnetic resonance imaging contrast agents
US6232295B1 (en) * 1994-10-12 2001-05-15 Jon Faiz Kayyem Cell-specific contrast agent and gene delivery vehicles
US20020025296A1 (en) 1994-10-21 2002-02-28 Knaus Edward E. Combined use of nucleoside analogues and gene transfection for tissue imaging and therapy
US5707605A (en) 1995-06-02 1998-01-13 Research Corporation Technologies Magnetic resonance imaging agents for the detection of physiological agents
US6180389B1 (en) * 1997-01-03 2001-01-30 The Research And Development Institute, Inc. Virion-constrained nanoparticles comprising a plant virion coat protein shell and encapsulated guest molecules
WO1998033809A1 (en) 1997-01-31 1998-08-06 The General Hospital Corporation Compositions and methods for imaging gene expression
ATE426036T1 (de) 1997-11-14 2009-04-15 Cedars Sinai Medical Center Transfektion und transfer nicht humaner mannlicher keimzellen zur generierung transgener nicht humaner saugetiere
US6511967B1 (en) 1999-04-23 2003-01-28 The General Hospital Corporation Use of an internalizing transferrin receptor to image transgene expression
US6495355B1 (en) 1999-06-22 2002-12-17 The Board Of Trustees Of The Leland Stanford Junior University Red-shifted luciferase
US6812339B1 (en) 2000-09-08 2004-11-02 Applera Corporation Polymorphisms in known genes associated with human disease, methods of detection and uses thereof
CA2478120C (en) 2002-03-07 2016-01-12 Carnegie Mellon University Contrast agents containing ferritin for magnetic resonance imaging and methods related thereto
DE60330767D1 (de) 2002-05-10 2010-02-11 New Century Pharmaceuticals Ferritinfusionsproteine zur verwendung für impfstoffe und andere anwendungen

Also Published As

Publication number Publication date
IL163937A (en) 2010-11-30
EP1487499A2 (en) 2004-12-22
AU2003220084A1 (en) 2003-09-22
JP2005518816A (ja) 2005-06-30
EP1487499B1 (en) 2009-06-10
IL163937A0 (en) 2005-12-18
US8084017B2 (en) 2011-12-27
ES2327912T3 (es) 2009-11-05
EP1487499A4 (en) 2005-11-16
AU2003220084B2 (en) 2008-08-28
ATE433331T1 (de) 2009-06-15
CA2478120A1 (en) 2003-09-18
CA2478120C (en) 2016-01-12
US20030219385A1 (en) 2003-11-27
DE60327927D1 (de) 2009-07-23
AU2008249217B2 (en) 2012-03-08
WO2003075747A3 (en) 2004-03-25
AU2008249217A1 (en) 2008-12-18
JP2011092208A (ja) 2011-05-12
WO2003075747A2 (en) 2003-09-18

Similar Documents

Publication Publication Date Title
DK1487499T3 (da) Kontrastmidler til magnetisk resonansbilleddannelse og relaterede fremgangsmåder
WO2006099516A3 (en) Methods for magnetic resonance imaging
ATE420879T1 (de) Indolizine als kinaseproteinhemmer
ATE349446T1 (de) Amyloid plaque aggregationshemmer und diagnostische bilderzeugungsmittel
ATE354573T1 (de) ßPYRAZOLVERBINDUNGEN, DIE SICH ALS PROTEINKINASEINHIBITOREN EIGNENß
CY1106366T1 (el) Ενωση λακταμης για την αναστολη της απελευθερωσης ή της συνθεσης βητα-αμυλοειδους πεπτιδιου
IS6316A (is) Aðferð til erfðafræðilegra greininga
DK1874818T3 (da) TGF-Beta 1-specifikke antistoffer
DK1543002T3 (da) Fremstilling af 1H-imidazo (4,5-c) quinolin-4-aminer via 1H-imidazo (4,5-c) quinolin-4-phtalimid mellemprodukter
DK1247097T3 (da) Fremgangsmåde til bestemmelse af effektiviteten af cancerterapi
CY1111225T1 (el) Νεα πεπτιδια ως αναστολεις πρωτεασης νs3-σερινης ιου ηπατiτιδας c
DE602004025101D1 (de) Humane anti-humane cd3-bindungsmoleküle
TR200103390T2 (tr) Proteaz inhibitörleri olan yeni bileşikler ve terkipler.
WO2003016923A3 (en) Hydroxypyridonate and hydroxypyrimidinone chelating agents
CY1105980T1 (el) Βελτιωμενη διαδικασια παρασκευης υδροβρωμικου αλατος του αλφα-πολυμορφικου ελετριπτανιου
NO20060535L (no) Aztreonam-L-lysin og fremgangsmater for fremstilling av dette
DE60223176D1 (de) Metallkomplexverbindungen
DE60320207D1 (de) N- oder C-terminale Peptid-Auswahlmethode für Proteomics
ATE522230T1 (de) Biphenyle als bilderzeugungsmittel bei der alzheimerschen krankheit
DE60203120D1 (de) Imidazopyridinone als p38 map kinase inhibitoren
MXPA03007413A (es) Composicion y metodo para tratar enfermedades inflamatorias.
NO20025738D0 (no) Metode
EP1265073A3 (en) Methods for determining plasma free drug concentration
DE59809283D1 (de) Inhibitoren für den urokinaserezeptor
NO20033921L (no) Inhibitor av monoaminopptak